Back to search

Article

Harnessing PROTAC technology to combat stress hormone receptor activation

2023-03-18

Abstract excerpt

Counteracting the overactivation of glucocorticoid receptors (GR) is an important therapeutic goal in stress-related psychiatry and beyond. The only clinically approved GR antagonist lacks selectivity and induces unwanted side effects. To complement existing tools of small-molecule-based inhibitors, we present a highly potent, novel catalytically-driven GR degrader, KH-103, based on proteolysis-targeting chimera t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c7a6daa-01fe-54c4-88ce-4696c1e0de46
DOI
10.1101/2023.03.17.533120
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing PROTAC technology to combat stress hormone receptor activationDOI 10.1101/2023.03.17.533120
Select a neighboring publication to make it the new centre.